Literature DB >> 16927185

General trends in the desolvation behavior of calcium salts.

Faraj Atassi1, Stephen R Byrn.   

Abstract

PURPOSE: This paper is concerned with the solid-state characterization of dehydrated calcium salts as well as the effect of dehydration on the physical properties of these salts.
METHODS: The salts were analyzed by X-ray powder diffraction (XRPD), single crystal X-ray and polarized light microscopy (PLM).
RESULTS: Our research was able to identify three general behaviors of the desolvation of calcium salts of carboxylic acids. Upon desolvation, ethanolate and pentahydrate calcium indomethacin (CaIndo and CaInd2, respectively) stayed crystalline, fenoprofen calcium (CaFEN), calcium ketoprofen (CaKTN), calcium salicylate (CaSAL), calcium mefenamate (CaMEF) and calcium tolfenamate (CaTOLF) became mesophases, while calcium diflunisal became partially crystalline. On the other hand, the solubility studies of CaFEN, CaKTN and CaSAL showed that all dehydrated calcium salts had higher solubility than their crystalline counterparts and amorphous CaKTN had higher solubility than mesomorphous CaKTN.
CONCLUSIONS: Several factors influence the desolvation behavior of calcium salts. We believe the flexibility of the benzene rings in CaKTN, CaFEN, CaMEF and CaTOLF was important for these products to become mesomorphous when they loose their crystalline water; meanwhile, CaDIF where the two benzene rings are coplanar remained crystalline when heated. Additionally, the existence of water channels and the hydrogen bonding networks in the crystals is hypothesized to play an important role in the desolvation behavior of these materials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927185     DOI: 10.1007/s11095-006-9015-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  In search of clarity.

Authors:  Gautam R Desiraju
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

2.  Solid-state phase transitions initiated by water vapor sorption of crystalline L-660,711, a leukotriene D4 receptor antagonist.

Authors:  E B Vadas; P Toma; G Zografi
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 3.  Pharmaceutical liquid crystals: the relevance of partially ordered systems.

Authors:  Cynthia L Stevenson; David B Bennett; David Lechuga-Ballesteros
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

Review 4.  Thermotropic liquid crystalline drugs.

Authors:  Heike Bunjes; Thomas Rades
Journal:  J Pharm Pharmacol       Date:  2005-07       Impact factor: 3.765

5.  Properties and stability of a liquid crystal form of cyclosporine-the first reported naturally occurring peptide that exists as a thermotropic liquid crystal.

Authors:  David Lechuga-Ballesteros; Ahmad Abdul-Fattah; Cynthia L Stevenson; David B Bennett
Journal:  J Pharm Sci       Date:  2003-09       Impact factor: 3.534

6.  Structure and physical stability of hydrates and thermotropic mesophase of calcium benzoate.

Authors:  Akira Terakita; Stephen R Byrn
Journal:  J Pharm Sci       Date:  2006-05       Impact factor: 3.534

7.  Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.

Authors:  James Patterson; Andrew Bary; Thomas Rades
Journal:  Int J Pharm       Date:  2002-10-24       Impact factor: 5.875

8.  Solid-state chemistry of cromolyn sodium (disodium cromoglycate).

Authors:  J S Cox; G D Woodard; W C McCrone
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

9.  Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR.

Authors:  Cynthia L Stevenson; Mandy M Tan; David Lechuga-Ballesteros
Journal:  J Pharm Sci       Date:  2003-09       Impact factor: 3.534

  9 in total
  1 in total

1.  Rapid insight into heating-induced phase transformations in the solid state of the calcium salt of atorvastatin using multivariate data analysis.

Authors:  Niels Peter Aae Christensen; Bernard Van Eerdenbrugh; Kaho Kwok; Lynne S Taylor; Andrew D Bond; Thomas Rades; Jukka Rantanen; Claus Cornett
Journal:  Pharm Res       Date:  2012-11-10       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.